Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Conditions That May Defer Blood Donation While on GLP-1 Therapy Blood banks may defer donors with poorly controlled diabetes, regardless of whether they take GLP-1 medications
This decision should be made collaboratively with your healthcare provider based on individual circumstances, treatment goals, and available options
Comparison to Other Routes Intravenous: 100% bioavailability (by definitionthe full dose enters circulation) Subcutaneous: Likely 6090% bioavailability (depends on absorption rate) Oral: ~38% systemic bioavailability This is why some researchers hypothetically prefer injected routeshigher bioavailability means lower nominal doses are needed
10.1371/journal.pone.0015384 PLoS One 35 CreganS
For more information, contact us today
US$ 23.18
US$ 25.28
US$ 22.89
US$ 25.88
US$ 26.07
US$ 26.72
US$ 28.89
US$ 26.10
